Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva CFO says company did not conspire to fix prices - www.israelhayom.com
Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: report | Fierce Pharma
Setback for Teva as court dismisses Copaxone lawsuit - PMLiVE
Teva stock plummets by double figures on back of U.S. government kickback lawsuit | Ctech
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva agrees to $4.25 billion settlement in opioid lawsuit
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceuticals will pay $420 million in a federal case
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | KTLA
Opioid Lawsuit Against Teva Pharma
Texas settles another opioid lawsuit, wins $225 million against Teva
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
